Identification of a minimal region of loss on the short arm of chromosome I in Wilms tumor

Genes Chromosomes and Cancer

Volumn 46, Issue 4, 2007, Pages 327-335

  Tamimi, Yahya ^a   Ziebar, Kay ^a   Desaulniers, Nancy ^a   Dietrich, Kevin ^a   Grundy, Paul ^a  

^a UNIVERSITY OF ALBERTA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER GENETICS; CHROMOSOME 1P; CHROMOSOME ABERRATION; CHROMOSOME ANALYSIS; CHROMOSOME MAP; CLEAR CELL SARCOMA; CONTROLLED STUDY; DENATURING HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; DNB5 GENE; GENE LOCATION; GENE LOCUS; GENETIC ANALYSIS; GENETIC ASSOCIATION; GENETIC LINKAGE; HETEROZYGOSITY LOSS; HUMAN; HUMAN TISSUE; ICAT GENE; KIDNEY CARCINOMA; LZIC GENE; MICROSATELLITE MARKER; NEPHROBLASTOMA; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHABDOID TUMOR; TUMOR SUPPRESSOR GENE;

CHROMOSOME DELETION; CHROMOSOMES, HUMAN, PAIR 1; HUMANS; LOSS OF HETEROZYGOSITY; MICROSATELLITE REPEATS; WILMS TUMOR;

EID: 33947163854     PISSN: 10452257     EISSN: 10982264     Source Type: Journal    
DOI: 10.1002/gcc.20413     Document Type: Article

References (32)

1. Amler LC, Bauer A, Corvi R, Dihlmann S, Praml C, Cavenee WK, Schwab M, Hampton GM. 2000. Identification and characterization of novel genes located at the t(1;15)(p36.2;q24) translocation breakpoint in the neuroblastoma cell line NGP. Genomics 64:195-202.
2. Barbashina V, Salazar P, Holland EC, Rosenblum MK, Ladanyi M. 2005. Allelic losses at 1p36 and 19q13 in gliomas: Correlation with histologic classification, definition of a 150-kb minimal deleted region on 1p36, and evaluation of CAMTA1 as a candidate tumor suppressor gene. Clin Cancer Res 11:1119-1128.
3. Bardeesy N, Beckwith JB, Pelletier J. 1995. Clonal expansion and attenuated apoptosis in Wilms' tumors are associated with p53 gene mutations. Cancer Res 55:215-219.
4. Beaty MW, Quezado M, Sobel ME, Duray P, Merino MJ. 2005. Loss of heterozygosity on chromosome 1 and 9 and hormone receptor analysis of metastatic malignant melanoma presenting in breast. Int J Surg Pathol 13:9-18.
5. Breslow NE, Beckwith JB. 1982. Epidemiological features of Wilms' tumor: Results of the National Wilms' Tumor Study. J Natl Cancer Inst 68:429-436.
6. Caren H, Ejeskar K, Fransson S, Hesson L, Latif F, Sjoberg RM, Krona C, Martinsson T. 2005. A cluster of genes located in 1p36 are down-regulated in neuroblastomas with poor prognosis, but not due to CpG island methylation. Mol Cancer 4:10.
7. Chen YY, Takita J, Chen YZ, Yang HW, Hanada R, Yamamoto K, Hayashi Y. 2003. Genomic structure and mutational analysis of the human KIF1Bα gene located at 1p36.2 in neuroblastoma. Int J Oncol 23:737-744.
8. Cheung TH, Lo KW, Yim SF, Poon CS, Cheung AY, Chung TK, Wong YF. 2005. Clinicopathologic significance of loss of heterozygosity on chromosome 1 in cervical cancer. Gynecol Oncol 96:510-515.
9. D'Angio GJ, Breslow N, Beckwith JB, Evans A, Baum H. deLorimier A, Fernbach D, Hrabovsky E, Jones B, Kelalis P. 1989. Treatment of Wilms' tumor. Results of the Third National Wilms' Tumor Study. Cancer 64:349-360.
10. Fearon ER, Vogelstein B. 1990. A genetic model for colorectal tumorigenesis. Cell 61:759-767.
11. Getman ME, Houseal TW, Miller GA, Grundy PE, Cowell JK, Landes GM. 1998. Comparative genomic hybridization and its application to Wilms' tumorigenesis. Cytogenet Cell Genet 82:284-290.
12. Grundy P, Telzerow P, Moksness J, Breslow NE. 1996. Clinicopathologic correlates of loss of heterozygosity in Wilm's tumor: A preliminary analysis. Med Pediatr Oncol 27:429-433.
13. Grundy PE, Breslow NE, Li S, Perlman E, Beckwith JB, Ritchey ML, Shamberger RC, Haase GM, D'Angio GJ, Donaldson M, Coppes MJ, Malogolowkin M, Shearer P, Thomas PR, Macklis R, Tomlinson G, Huff V, Green DM, National Wilms Tumor Study Group. 2005. Loss of heterozygosity for chromosomes 1p and 16q is an adverse prognostic factor in favorable-histology Wilms tumor: A report from the National Wilms Tumor Study Group. J Clin Oncol 23:7312-7321.
14. Grundy PE, Telzerow PE, Breslow N, Moksness J, Huff V, Paterson MC. 1994. Loss of heterozygosity for chromosomes 16q and 1p in Wilms' tumors predicts an adverse outcome. Cancer Res 54:2331-2333.
15. Grundy RG, Pritchard J, Scambler P, Cowell JK. 1998. Loss of heterozygosity on chromosome 16 in sporadic Wilms' tumour. Br J Cancer 78:1181-1187.
16. Kaneko Y, Homma C, Maseki N, Sakurai M, Hata J. 1991. Correlation of chromosome abnormalities with histological and clinical features in Wilms' and other childhood renal tumors. Cancer Res 51:5937-5942.
17. Katoh M. 2001. Molecular cloning and characterization of LZIC, a novel gene encoding ICAT homologous protein with leucine zipper domain. Int J Mol Med 8:611-615.
18. Katoh M, Katoh M. 2003. Identification and characterization of FLJ10737 and CAMTA1 genes on the commonly deleted region of neuroblastoma at human chromosome 1p36.31-p36.23. Int J Oncol 23:1219-1224.
19. Knudson A, Jr. 1993. Genetics of tumors of the head and neck. Arch Otolaryngol Head Neck Surg 119:735-737.
20. Koesters R, Ridder R, Kopp-Schneider A, Betts D, Adams V, Niggli F, Briner J, von Knebel Doeberitz M. 1999. Mutational activation of the β-catenin proto-oncogene is a common event in the development of Wilms' tumors. Cancer Res 59:3880-3882.
21. Krona C, Ejeskar K, Abel F, Kogner P, Bjelke J, Bjork E, Sjoberg RM, Martinsson T. 2003. Screening for gene mutations in a 500 kb neuroblastoma tumor suppressor candidate region in chromosome 1p; mutation and stage-specific expression in UBE4B/UFD2. Oncogene 22:2343-2351.
22. Lahortiga I, Vazquez I, Belloni E, Roman JP, Gasparini P, Novo FJ, Zudaire I, Pelicci PG, Hernandez JM, Calasanz MJ, Odero MD. 2005. FISH analysis of hematological neoplasias with 1p36 rearrangements allows the definition of a cluster of 2.5 Mb included in the minimal region deleted in 1p36 deletion syndrome. Hum Genet 116:476-485.
23. Maris JM, Jensen J, Sulman EP, Beltinger CP, Allen C, Biegel JA, Brodeur GM, White PS. 1997. Human Kruppel-related 3 (HKR3): A candidate for the 1p36 neuroblastoma tumour suppressor gene? Eur J Cancer 33:1991-1996.
24. Mason JE, Goodfellow PJ, Grundy PE, Skinner MA. 2000. 16q loss of heterozygosity and microsatellite instability in Wilms' tumor. J Pediatr Surg 35:891-896, discussion 896-897.
25. Mathysen D, Van Roy N, Van Hul W, Laureys G, Ambros P, Speleman F, Wuyts W. 2004. Molecular analysis of the putative tumour-suppressor gene EXTL1 in neuroblastoma patients and cell lines. Eur J Cancer 40:1255-1261.
26. Maw MA, Grundy PE, Millow LJ, Eccles MR, Dunn RS, Smith PJ, Feinberg AP, Law DJ, Paterson MC, Telzerow PE. 1992. A third Wilms' tumor locus on chromosome 16q. Cancer Res 52:3094-3098.
27. Mori T, Nomoto S, Koshikawa K, Fujii T, Sakai M, Nishikawa Y, Inoue S, Takeda S, Kaneko T, Nakao A. 2005. Decreased expression and frequent allelic inactivation of the RUNX3 gene at 1p36 in human hepatocellular carcinoma. Liver Int 25:380-388.
28. Morrison DJ, English MA, Licht JD. 2005. WT1 induces apoptosis through transcriptional regulation of the proapoptotic Bcl-2 family member Bak. Cancer Res 65:8174-8182.
29. Peres EM, Savasan S, Cushing B, Abella S, Mohamed AN. 2004. Chromosome analyses of 16 cases of Wilms tumor: Different pattern in unfavorable histology. Cancer Genet Cytogenet 148:66-70.
30. Steenman M, Redeker B, de Meulemeester M, Wiesmeijer K, Voute PA, Westerveld A, Slater R, Mannens M. 1997. Comparative genomic hybridization analysis of Wilms tumors. Cytogenet Cell Genet 77:296-303.
31. Tamimi Y, Dietrich K, Stone K, Grundy P. 2006. Paired box genes, PAX-2 and PAX-8, are not frequently mutated in Wilms tumor. Mutat Res 601:46-50.
32. Wadey RB, Pal N, Buckle B, Yeomans E, Pritchard J, Cowell JK. 1990. Loss of heterozygosity in Wilms' tumour involves two distinct regions of chromosome 11. Oncogene 5:901-907.